Owens & Minor Inventory Turnover Ratio 2006-2019 | OMI
Owens & Minor inventory turnover ratio from 2006 to 2019. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period.
| Owens & Minor Inventory Turnover Ratio Historical Data | |||
|---|---|---|---|
| Date | |||
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.198B | $9.839B |
| Owens & Minor, Inc. is a global healthcare solutions company dedicated to Connecting the World of Medical Products to the Point of CareSM by providing vital supply chain services to healthcare providers and manufacturers of healthcare products. Owens & Minor provides logistics services across the spectrum of medical products from disposable medical supplies to devices and implants. With logistics platforms strategically located in the United States and Europe, Owens & Minor serves markets where three quarters of global healthcare spending occurs. Owens & Minor's customers span the healthcare market from independent hospitals to large integrated healthcare networks, as well as group purchasing organizations, healthcare products manufacturers, the federal government, and healthcare patients at home through the Byram Healthcare subsidiary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $147.856B | 28.70 |
| Medtronic (MDT) | Ireland | $133.874B | 19.12 |
| Stryker (SYK) | United States | $76.669B | 27.36 |
| Boston Scientific (BSX) | United States | $59.033B | 28.30 |
| Baxter (BAX) | United States | $41.839B | 26.37 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $29.060B | 0.00 |
| Coloplast (CLPBY) | Denmark | $25.618B | 40.90 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.965B | 16.04 |
| Lonza Group Ag (LZAGY) | Switzerland | $24.947B | 0.00 |
| Terumo (TRUMY) | Japan | $23.393B | 26.90 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $19.274B | 0.00 |
| ResMed (RMD) | United States | $17.745B | 33.90 |
| Canopy Growth (CGC) | Canada | $12.161B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $12.027B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.308B | 49.34 |
| William Demant Holdings (WILYY) | Denmark | $7.651B | 0.00 |
| Insulet (PODD) | United States | $7.203B | 524.78 |
| Aurora Cannabis (ACB) | Canada | $7.109B | 70.10 |
| Perrigo (PRGO) | Ireland | $7.004B | 11.84 |
| Hill-Rom Holdings (HRC) | United States | $6.993B | 21.20 |
| GN STORE NORD (GNNDY) | Denmark | $6.409B | 32.73 |
| Haemonetics (HAE) | United States | $6.325B | 51.63 |
| ICU Medical (ICUI) | United States | $5.135B | 30.64 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $5.057B | 0.00 |
| Neogen (NEOG) | United States | $3.349B | 54.45 |
| NuVasive (NUVA) | United States | $2.982B | 24.36 |
| Hutchison China MediTech (HCM) | China | $2.925B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $2.711B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.420B | 51.57 |
| Quidel (QDEL) | United States | $2.309B | 23.96 |
| Cardiovascular Systems (CSII) | United States | $1.598B | 917.80 |
| Aphria (APHA) | $1.579B | 0.00 | |
| Phibro Animal Health (PAHC) | United States | $1.229B | 18.41 |
| AtriCure (ATRC) | United States | $1.218B | 0.00 |
| VAREX IMAGING (VREX) | United States | $1.187B | 25.19 |
| Lantheus Holdings (LNTH) | United States | $1.089B | 28.93 |
| NanoString Technologies (NSTG) | United States | $1.056B | 0.00 |
| PetIQ (PETQ) | United States | $0.994B | 24.14 |
| MacroGenics (MGNX) | United States | $0.777B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.765B | 21.47 |
| Cerus (CERS) | United States | $0.758B | 0.00 |
| Quanterix (QTRX) | United States | $0.753B | 0.00 |
| Omeros (OMER) | United States | $0.750B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.698B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.572B | 27.71 |
| Surmodics (SRDX) | United States | $0.543B | 78.88 |
| OraSure Technologies (OSUR) | United States | $0.531B | 24.43 |
| Meridian Bioscience (VIVO) | United States | $0.476B | 14.56 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.404B | 0.00 |
| Vapotherm (VAPO) | United States | $0.345B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.320B | 22.13 |
| BioLife Solutions (BLFS) | United States | $0.304B | 95.24 |
| Zynex (ZYXI) | United States | $0.250B | 25.67 |
| Bovie Medical (APYX) | United States | $0.236B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.227B | 0.00 |
| Chimerix (CMRX) | United States | $0.188B | 0.00 |
| United Health Products (UEEC) | United States | $0.175B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.170B | 0.00 |
| Female Health (VERU) | United States | $0.146B | 0.00 |
| Fonar (FONR) | United States | $0.139B | 7.33 |
| Chembio Diagnostics (CEMI) | United States | $0.098B | 0.00 |
| United-Guardian (UG) | United States | $0.094B | 20.65 |
| InfuSystems Holdings (INFU) | United States | $0.090B | 0.00 |
| Surface Oncology (SURF) | United States | $0.075B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.060B | 20.75 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.058B | 0.00 |
| MRI INTERVENTNS (MRIC) | United States | $0.052B | 0.00 |
